CD40LG and systemic lupus erythematosus: Previous clinical development of monoclonal antibodies against CD40L (BG9588 and IDEC-131) in SLE has been complicated by cardiovascular thromboembolic events, which may have been caused by immune complexes consisting of soluble CD40L and anti-CD40L antibodies [16–18].